OncoZenge AB's total assets for Q2 2025 were kr15.27M, an increase of 30.00% from the previous quarter. DE:8LY total liabilities were kr2.44M for the fiscal quarter, a 39.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.